U.S. Agencies Work With WHO Despite Trump Threat to Cut Ties
(Bloomberg) -- Top U.S. health officials said they are still working closely with the World Health Organization even after President Donald Trump said last week he planned to terminate the U.S. relationship with the group for being too deferential to China.
National Institute of Allergy and Infectious Diseases Director Anthony Fauci and Centers for Disease Control and Prevention Director Robert Redfield both suggested they are maintaining ties with the WHO Thursday. Trump administration officials have been struggling during the coronavirus pandemic to separate politics from public health, having to tread lightly when the president makes erroneous statements or takes actions they don't agree with.
“The WHO continues to be a close colleague or ours,” Redfield told House lawmakers at a hearing. “We continue to have a close collaboration with the WHO.”
Fauci told Politico in a story published Thursday that the WHO is an important part of the response to any outbreak.
“So from my standpoint, I have in the past and will continue to have a close relationship with the WHO,” Fauci said.
Trump's decision to cut ties with the WHO has been criticized by Republicans and Democrats, as well as major medical organizations. He has previously pledged to freeze funding to the global health group, which helps coordinate public health efforts around the globe but has faced increasing scrutiny from the White House over its relationship to China during the pandemic.
The U.S. has historically been the WHO's largest contributor, providing $400 million to $500 million in mandatory and voluntary contributions.
The White House didn't immediately respond to a request for comment.
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
